DoD supports further development of plasma technology

10/6/2011 | American City Business Journals

The Defense Department has awarded Entegrion a $43.7 million contract to further develop the biotech company's Resusix plasma product. The technology, which the company says provides a better alternative to frozen blood plasma, would enable military staffers to dry and store plasma that they could use in combat situations.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC